A frontal lobotomy is a surgical procedure that severs nerve connections in the brain’s prefrontal cortex, the region behind your forehead responsible for personality, decision-making, and emotional regulation. Developed in the 1930s and widely performed through the 1950s, the surgery was intended to treat severe mental illness by physically cutting the pathways between the frontal lobes and deeper brain structures. An estimated 60,000 lobotomies were performed in the United States and Europe between 1936 and 1956, and the procedure left lasting damage in the vast majority of patients.
What the Surgery Actually Did
The prefrontal cortex sits at the very front of the brain and connects to the thalamus, a relay station deep in the center that processes sensory information and channels it to the rest of the brain. In people with severe psychiatric conditions like schizophrenia or chronic depression, the theory was that these connections carried recurring, disordered thought patterns that couldn’t be interrupted by other means. A lobotomy physically destroyed those connections.
The original version of the procedure, developed by Portuguese neurologist Egas Moniz in 1935, involved drilling two holes in the skull above the temples and using a specially designed instrument called a leukotome to cut the nerve fibers running between the thalamus and the frontal lobes. Early attempts used pure ethyl alcohol injected directly into the prefrontal cortex to dissolve the neural tracts. Later, Moniz refined the technique to use a surgical tool that could more precisely sever the target fibers, though “precise” is a generous description for what remained a crude operation.
The Transorbital “Ice Pick” Method
In 1946, American psychiatrist Walter Freeman introduced a faster, cheaper, and far more disturbing version. Rather than drilling through the skull, Freeman inserted a thin, pointed instrument resembling an ice pick through the patient’s eye socket, above the eyeball, and into the frontal lobe. He then swept the instrument side to side to sever connections between the two frontal lobes. The patient was “sedated” beforehand with an electroconvulsive shock rather than general anesthesia.
Freeman designed this transorbital approach so it could be performed in minutes, in a doctor’s office, without a surgeon present. This made the procedure accessible to state psychiatric hospitals that had neither the staff nor the funding for conventional brain surgery. Freeman personally performed over 4,000 lobotomies and traveled the country promoting the technique. In 1949 alone, more than 5,000 lobotomies were performed in the United States.
Who Received Lobotomies
The procedure was originally intended for patients with severe, treatment-resistant psychiatric conditions. Schizophrenia, severe paranoia, chronic depression, extreme anxiety, and obsessive-compulsive disorder were the primary diagnoses. Moniz’s reasoning was that these illnesses involved fixed, repetitive thought patterns that dominated normal mental function, and that severing the neural connections sustaining those patterns could provide relief.
In practice, lobotomies were performed far more broadly than that clinical rationale justified. Patients in overcrowded state institutions, people whose behavior was considered disruptive or socially unacceptable, and individuals who had little ability to consent were subjected to the procedure. Women and institutionalized patients were disproportionately represented. The bar for “treatment-resistant” was often low, and the decision to operate frequently reflected institutional convenience as much as medical judgment.
What Happened to Patients Afterward
The damage was severe and, for most patients, permanent. A follow-up study tracking lobotomy patients over a decade found that 91% developed a measurable personality defect, and 12% developed epilepsy as a direct complication. The personality changes were often described as “blunting.” Patients lost initiative, motivation, and the ability to plan or think abstractly. Emotional responses became flat. Many lost the capacity for social awareness, becoming indifferent to others and unable to function independently.
Some patients did experience a reduction in their most extreme psychiatric symptoms, which is why the procedure gained traction in the first place. A person tormented by unrelenting anxiety or violent psychotic episodes might become calmer. But that calm came at the cost of something fundamental. Patients who had been agitated became passive. People who had been sharp became dull. The operation didn’t treat mental illness so much as it destroyed the parts of the brain responsible for complex thought and emotional depth, leaving a quieter but profoundly diminished person behind.
Egas Moniz received the Nobel Prize in Physiology or Medicine in 1949 for developing the procedure. That award remains one of the most controversial in Nobel history.
Why Lobotomies Stopped
The single biggest factor in ending the lobotomy era was the arrival of the first effective psychiatric medication. Chlorpromazine, available starting in 1954, could reduce psychotic symptoms, agitation, and disordered thinking without surgery. For the first time, doctors had a treatment for conditions like schizophrenia that didn’t require destroying brain tissue. As antipsychotic medications became standard, larger medical centers abandoned the lobotomy. The procedure fell into disrepute by the late 1950s.
Growing public awareness of the damage lobotomies caused also played a role. Journalists, former patients, and families of those who had been lobotomized began speaking out. The medical community increasingly recognized that the procedure’s outcomes were unpredictable, its side effects devastating, and its scientific basis thin. By the 1970s, lobotomies had essentially ceased in the United States and most of Europe.
Modern Psychiatric Brain Procedures
The lobotomy’s legacy made the medical world deeply cautious about any surgery targeting the brain for psychiatric purposes, but the underlying idea that specific brain circuits contribute to mental illness has proven correct. Today’s approaches look nothing like a lobotomy. Deep brain stimulation (DBS) uses implanted electrodes to deliver mild electrical pulses to specific brain regions, modulating their activity without destroying tissue. It is currently FDA-approved for obsessive-compulsive disorder and is being studied for treatment-resistant depression and addiction.
A newer technique, MRI-guided focused ultrasound, can target deep brain structures without any incision at all, using sound waves focused through the skull. These modern methods are reversible or adjustable, guided by detailed brain imaging, and reserved for patients who haven’t responded to years of conventional treatment. They represent the opposite philosophy from the lobotomy: targeted, reversible, and carefully controlled rather than broad, permanent, and indiscriminate.